Pages that link to "Q49105200"
Jump to navigation
Jump to search
The following pages link to Association Between Increased Plasma Levels of Aldosterone and Decreased Systemic Arterial Compliance in Subjects With Essential Hypertension (Q49105200):
Displaying 50 items.
- Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness (Q22306395) (← links)
- Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease (Q27024623) (← links)
- Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared (Q28289525) (← links)
- Mineralocorticoid receptor antagonists and endothelial function (Q28645984) (← links)
- Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats (Q32055195) (← links)
- Aldosterone and vascular damage (Q33181046) (← links)
- Aldosterone antagonists in the treatment of hypertension and target organ damage (Q34251366) (← links)
- Pathophysiological effects of aldosterone in cardiovascular tissues (Q34336943) (← links)
- New perspectives on the role of aldosterone excess in cardiovascular disease (Q34366011) (← links)
- Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness (Q34632600) (← links)
- Clinical applications of arterial stiffness: therapeutics and pharmacology (Q34647819) (← links)
- Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). (Q34782535) (← links)
- Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation (Q34787751) (← links)
- Arterial stiffness: a brief review (Q34807187) (← links)
- Aldosterone as a target in congestive heart failure (Q35106480) (← links)
- Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults. (Q35685538) (← links)
- Pulse pressure, heart rate, and drug treatment of hypertension (Q35765154) (← links)
- Aldosterone and cardiovascular remodelling: focus on myocardial failure (Q35770232) (← links)
- Role of the selective aldosterone receptor blockers in arterial hypertension (Q35770241) (← links)
- Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design (Q35810347) (← links)
- Novel antihypertensive agents (Q35842537) (← links)
- Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention (Q36009879) (← links)
- Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study (Q36623035) (← links)
- New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. (Q36788871) (← links)
- Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction (Q36800757) (← links)
- Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity (Q36829138) (← links)
- Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues (Q36858827) (← links)
- Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis (Q36944645) (← links)
- How steroid hormones act on the endothelium--insights by atomic force microscopy (Q37049071) (← links)
- Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children (Q37304780) (← links)
- Role of cellular mechanics in the function and life span of vascular endothelium (Q37841193) (← links)
- Arterial stiffness: from physiology to clinical implications. (Q37879653) (← links)
- Vascular compliance in blood pressure (Q37898985) (← links)
- Relations between large artery structure and function and aldosterone (Q37913954) (← links)
- Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms (Q38123754) (← links)
- Aldosterone synthase inhibition in hypertension (Q38126805) (← links)
- Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation? (Q38544207) (← links)
- Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension. (Q38955652) (← links)
- The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension (Q39238938) (← links)
- Arterial stiffness and the renin-angiotensin-aldosterone system (Q45139058) (← links)
- Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas (Q46621475) (← links)
- Auto-amplification of cortisol actions in human carotid atheroma is linked to arterial remodeling and stroke (Q46664468) (← links)
- Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking (Q46713614) (← links)
- Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists. (Q47120314) (← links)
- Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension. (Q53476197) (← links)
- Use of medications to lower urine protein level in patients with diabetic kidney disease. (Q53906636) (← links)
- High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements? (Q77375358) (← links)
- Carotid ultrasound backscatter analysis in hypertensive and in healthy subjects (Q78431078) (← links)
- Preferential association of aldosterone synthase gene polymorphism with central blood pressure and wave reflections in hypertensive individuals (Q84242814) (← links)
- Primary aldosteronism associated with a giant coronary aneurysm after drug-eluting stent implantation (Q90379699) (← links)